Vivos (RDGL) 10-Q 15 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 10, 2017
Document And Entity Information
Entity Registrant Name	ADVANCED MEDICAL ISOTOPE Corp
Entity Central Index Key	1,449,349
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		44,712,897
Trading Symbol	ADMD
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,017

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash	$ 23,700	$ 27,889
Prepaid expenses		11,990
Total current assets	23,700	39,879
Fixed assets, net of accumulated depreciation	733	1,473
Other assets:
Deposits	644	644
Total other assets	644	644
Total assets	25,077	41,996
Current liabilities:
Accounts payable and accrued expenses	958,588	1,137,086
Related party accounts payable	190,763	109,718
Accrued interest payable	91,151	114,755
Payroll liabilities payable	442,078	499,502
Convertible notes payable, net	1,071,204	544,508
Derivative liability	89,464	324,532
Related party promissory note	383,771	332,195
Total current liabilities	3,227,019	3,062,296
Total liabilities	3,227,019	3,062,296
Mezzanine Equity:
Preferred stock, $.001 par value, 20,000,000 shares authorized Series A preferred stock, $.001 par value, 5,000,000 shares authorized; 2,964,702 and 3,773,592 shares issued and outstanding, respectively	11,744,233	14,144,571
Total mezzanine equity	11,744,233	14,144,571
Stockholders’ equity (deficit):
Common stock, $.001 par value; 2,000,000,000 shares authorized; 41,967,897 and 31,743,797 shares issued and outstanding, respectively	41,968	31,744
Paid in capital	43,298,063	40,672,825
Accumulated deficit	(58,286,206)	(57,869,440)
Total stockholders’ equity (deficit)	(14,946,175)	(17,164,871)
Total liabilities and stockholders’ equity (deficit)	$ 25,077	$ 41,996

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	20,000,000	20,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	2,000,000,000	2,000,000,000
Common stock, issued	41,967,897	31,743,797
Common stock, outstanding	41,967,897	31,743,797
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	2,964,702	3,773,592
Preferred stock, outstanding	2,964,702	3,773,592

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Revenues	$ 4,054	$ 4,054
Operating expenses
Sales and marketing expenses	25,998	11,836
Depreciation and amortization	740	738
Professional fees	134,604	70,969
Stock options granted	28,240
Payroll expenses	104,780	165,000
General and administrative expenses	74,407	438,042
Total operating expenses	368,769	686,585
Operating loss	(364,715)	(682,531)
Non-operating income (expense)
Interest expense	(527,951)	(49,209)
Net gain on sale of assets	2,800
Net gain (loss) on settlement of debt	147,710
Net gain (loss) on debt extinguishment	147,710
Net gain (loss) on derivative liability	325,390	(5,139,998)
Non-operating income (expense), net	(52,051)	(5,123,370)
Income (Loss) before Income Taxes	(416,766)	(5,805,901)
Income Tax Provision
Net Income (Loss)	$ (416,766)	$ (5,805,901)
Basic and Diluted Income (Loss) per Common Share	$ (0.0110)	$ (0.0029)
Weighted average common shares outstanding	38,021,103	19,969,341

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOW FROM OPERATING ACTIVITIES:
Net Loss	$ (416,766)	$ (5,805,901)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation of fixed assets	740	738
Amortization of licenses and intangible assets
Amortization of convertible debt discount	462,928	299,773
Gain on sale of assets	(2,800)
Preferred and common stock issued for loan fees		300,494
Stock options and warrants issued for services	28,240
Gain (loss) on derivative liability	(325,390)	5,139,998
Loss on settlement of debt	(147,711)	(65,837)
Penalties on notes payable		(332,274)
Changes in operating assets and liabilities:
Prepaid expenses	11,990	5,411
Accounts payable	109,110	(170,241)
Payroll liabilities	(57,424)	73,274
Accrued interest	61,425	(18,290)
Net cash used by operating activities	(275,658)	(572,855)
CASH FLOWS FROM INVESTING ACTIVITIES
Sale of fixed assets	2,800
Net cash from investing activities	2,800
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from shareholder advances	137,000
Proceeds from convertible debt	131,669	641,760
Net cash provided by financing activities	268,669	641,760
Net increase in cash	(4,189)	68,905
Cash, beginning of period	27,889	179,032
CASH, END OF PERIOD	23,700	247,937
Supplemental disclosures of cash flow information:
Cash paid for interest		9,920
Cash paid for income taxes

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies	NOTE 1: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES The accompanying condensed consolidated financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period presented. The results of operations for the three months ended March 31, 2017, are not necessarily indicative of the results that may be expected for any future period or the fiscal year ending December 31, 2017 and should be read in conjunction with the Company’s form 10-K for the year ended December 31, 2016. Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2017 and December 31, 2016, the balances reported for cash, prepaid expenses, accounts receivable, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis were calculated using the Black-Scholes pricing model and are as follows at March 31, 2017 and December 31, 2016: March 31, 2017 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 89,464 $ $ $ 89,464 Total Liabilities Measured at Fair Value $ 89,464 $ - $ - $ 89,464 December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 324,532 $ $ $ 324,532 Total Liabilities Measured at Fair Value $ 324,532 $ - $ - $ 324,532 Recent Accounting Pronouncements There are no recently issued accounting pronouncements that the Company believes are applicable or would have a material impact on the financial statements of the Company.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2: GOING CONCERN The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company has suffered recurring losses and used significant cash in support of its operating activities and the Company’s cash position is not sufficient to support the Company’s operations. Historically, the Company has relied upon outside investor funds to maintain the Company’s operations and develop the Company’s business. The Company anticipates it will continue to require funding from investors for working capital as well as business expansion during this fiscal year and it can provide no assurance that additional investor funds will be available on terms acceptable to us. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable time. In addition, the Company’s ability to continue as a going concern must be considered in light of the problems, expenses and complications frequently encountered by entrance into established markets and the competitive environment in which it operates. The Company anticipates a requirement of $1.5 million in funds over the next twelve months to maintain current operation activities. The Company may also require up to approximately $1.5 million to retire outstanding debt and past due payables. As of March 31, 2017 the Company has certain convertible promissory notes totaling approximately $45,000 that are currently due and payable (“ Outstanding Notes The Company requires funding of at least $1.5 million per year to maintain current operating activities. Over the next 12-24 months, the Company believes it will cost approximately $5 million to $10 million to fund: (1) the FDA approval process and initial deployment of the brachytherapy products and (2) initiate regulatory approval processes outside of the United States. The continued deployment of the brachytherapy products and a worldwide regulatory approval effort will require additional resources and personnel. The principal variables in the timing and amount of spending for the brachytherapy products in the next 12-24 months will be the FDA’s classification of the Company’s brachytherapy products as Class II or Class III devices (or otherwise) and any requirements for additional studies which may possibly include clinical studies. Thereafter, the principal variables in the amount of the Company’s spending and its financing requirements would be the timing of any approvals and the nature of the Company’s arrangements with third parties for manufacturing, sales, distribution and licensing of those products and the products’ success in the U.S. and elsewhere. The Company intends to fund its activities through strategic transactions such as licensing and partnership agreements or additional capital raises. As of March 31, 2017, the Company has $23,700 cash on hand. There are currently commitments to vendors for products and services purchased, accrued compensation expenses and the Company’s current lease commitments that in the absence of additional capital would result in a liquidation of the Company. The current level of cash is not enough to cover the fixed and variable obligations of the Company. Assuming the Company is successful in the Company’s sales/development effort it believes that it will be able to raise additional funds through strategic agreements or the sale of the Company’s stock to either current or new stockholders. There is no guarantee that the Company will be able to raise additional funds or to do so at an advantageous price. The financial statements do not include any adjustments relating to the recoverability and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. The Company plans to seek additional funding to maintain its operations through debt and equity financing and to improve operating performance through a focus on strategic products and increased efficiencies in business processes and improvements to the cost structure. There is no assurance that the Company will be successful in its efforts to raise additional working capital or achieve profitable operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Fixed Assets

Fixed Assets	3 Months Ended
	Mar. 31, 2017
Property, Plant and Equipment [Abstract]
Fixed Assets	NOTE 3: FIXED ASSETS Fixed assets consist of the following at March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 Production equipment $ 15,182 $ 1,938,532 Office equipment 14,593 32,769 29,775 1,971,301 Less accumulated depreciation (29,042 ) (1,969,828 ) $ 733 $ 1,473 Depreciation expense for the above fixed assets for the three months ended March 31, 2017 and 2016, respectively, was $740 and $738.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 4: INTANGIBLE ASSETS Intangible assets consist of the following at March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 License Fee $ - $ 112,500 Less accumulated amortization - (112,500 ) Patents and intellectual property - - Intangible assets net of accumulated amortization $ - $ - Amortization expense for the above intangible assets for the three months ended March 31, 2017 and 2016, respectively, was $0 and $0.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5: RELATED PARTY TRANSACTIONS Related Party Convertible Notes Payable The Company, in March 2017, combined the o n Rent Expenses The Company rents office space from a significant shareholder and director of the Company on a month to month basis with a monthly payment of $1,500. Rental expense for the three months ended March 31, 2017 and 2016 consisted of the following and is recorded in general and administrative expense: Three months ended March 31, 2017 Three months ended March 31, 2016 Office and warehouse space $ - $ - Corporate office 4,500 4,500 Total Rental Expense $ 4,500 $ 4,500

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2017
Convertible Notes Payable
Convertible Notes Payable	NOTE 6: CONVERTIBLE NOTES PAYABLE As of March 31, 2017 and December 31, 2016 the Company had the following convertible notes outstanding: March 31, 2017 December 31, 2016 Principal (net) Accrued Interest Principal (net) Accrued Interest July and August 2012 $1,060,000 Notes convertible into common stock at $4.60 per share, 12% interest, due December 2013 and January 2014 $ 45,000 $ 25,161 $ 95,000 50,365 May through October 2015 $605,000 Notes convertible into preferred stock at $1 per share, 8-10% interest, due September 30, 2015 - 17,341 - 17,341 October through December 2015 $613,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016, net of debt discount of $0 and $560,913, respectively - 5,953 - 5,953 January through March 2016 $345,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016 - 696 - 696 November 2016 $979,162 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $156,788 and $540,720, respectively 822,374 36,547 438,442 12,397 January and March 2017 $335,838 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $142,918 and $0, respectively 192,920 4,090 - - Penalties on notes in default 10,910 - 11,066 - Total Convertible Notes Payable, Net $ 1,071,204 $ 89,788 $ 544,508 $ 86,752 During the three months ending March 31, 2017, the Company received proceeds from new convertible notes of $131,669 and obtained advances from shareholders of $137,000 that were reclassified into convertible notes payable. The Company recorded original issue discounts on new convertible notes of $67,169, which also increased the debt discounts recorded on the convertible notes. The Company recorded $50,000 of payments on their convertible notes and a total gain on settlement of $5,831 representing the write-off of convertible note principal. Each of the Company’s convertible notes have a conversion rate that is variable. The Company therefore has accounted for such conversion features as derivative instruments (see Note 9). As a result of recording derivative liabilities at note inception, the Company increased the debt discount recorded on their convertible notes by $90,322 during the three months ending March 31, 2017. The Company also recorded amortization of $462,928 on their convertible note debt discounts. Lastly, the Company issued 49,320 shares of the Company’s Series A Convertible Preferred Stock (“ Series A Preferred

Common Stock Options And Warran

Common Stock Options And Warrants	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Common Stock Options And Warrants	NOTE 7: COMMON STOCK OPTIONS AND WARRANTS Common Stock Options The Company recognizes in the financial statements compensation related to all stock-based awards, including stock options and warrants, based on their estimated grant-date fair value. The Company has estimated expected forfeitures and is recognizing compensation expense only for those awards expected to vest. All compensation is recognized by the time the award vests. The following schedule summarizes the changes in the Company’s stock options: Weighted Weighted Options Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 2,402,500 $ 0.50-15 4.05 years $ - $ 0.81 Options granted - $ - - $ - Options exercised - $ - - $ - Options expired - $ - - $ - Balance at March 31, 2017 2,402,500 $ 0.50-15 3.81 years $ - $ 0.81 Exercisable at March 31, 2017 2,016,733 $ 0.50-15 3.73 years $ - $ 0.86 During the three months ended March 31, 2017 the Company recognized $28,240 worth of stock based compensation related to the vesting of its stock options. Common Stock Warrants The following schedule summarizes the changes in the Company’s stock warrants: Weighted Weighted Warrants Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 3,579,505 $ 0.10-10 0.52 years $ 749 $ 4.45 Warrants granted - $ - - $ Warrants exercised - $ - - $ Warrants expired/cancelled (15,000 ) $ - - $ 2.07 Balance at March 31, 2017 3,564,505 $ 0.40-10 0.28 years $ - $ 4.46 Exercisable at March 31, 2017 3,564,505 $ 0.40-10 0.28 years $ - $ 4.46

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2017
Equity [Abstract]
Stockholders' Equity	NOTE 8: STOCKHOLDERS’ EQUITY Common Stock During the three months ending March 31, 2017 the Company issued 762,000 shares of its common stock valued at $99,060 for the settlement of debt, 280,000 shares of its common stock valued at $43,400 for accounts payable, and 9,182,100 shares of its common stock valued at $2,464,762 for conversions of 858,210 shares of Series A Preferred. Preferred Stock During the three months ending March 31, 2017 the Company issued 49,320 shares of Series A Preferred valued at $64,424 as loan fees on convertible promissory notes.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	3 Months Ended
	Mar. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	NOTE 9: SUPPLEMENTAL CASH FLOW INFORMATION During the three months ending March 31, 2017 the Company had the following non-cash investing and financing activities: ● Increased convertible notes payable by $5,675, increased related party notes payable by $51,576, and decreased accrued interest by $57,251 for the reclassification of accrued interest to principal. ● Increased derivative liabilities for $90,322 to record a debt discount on convertible notes payable. ● Increased convertible notes payable and decreased loan from shareholder by $137,000 to roll proceeds from shareholder advances to a formal convertible note payable. ● Issued 49,320 shares of Series A preferred stock for loan fees that increased the convertible note debt discount by $64,424. ● Issued 9,182,100 shares of common stock in exchange for 858,210 shares of Series A Preferred decreasing preferred stock by $2,464,762, increasing common stock by $9,182, and increasing paid in capital by $2,455,580. ● Issued 280,000 shares of common stock valued at $43,400 for the reduction of $140,000 of accounts payable, recording $96,600 as a gain on extinguishment of debt. ● Issued 762,000 shares of common stock valued at $99,060 for the reduction of $50,000 of convertible notes payable and $27,778 of accrued interest, recording $21,282 as a gain on extinguishment of debt.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	NOTE 10: SUBSEQUENT EVENTS In April 2017 the Company received $43,750 in exchange for 10% convertible promissory notes due October 13, 2017. The Company issued 12,600 Series A Preferred as a loan fee on this note. In April 2017 the Company settled $86,767 of accounts payable in exchange for 825,000 of common stock. In April of 2017, the Company filed a Certificate of Merger with the Delaware Division of Corporations in order to merge the Company’s wholly-owned subsidiary, IsoPet Solutions Corporation, with and into the Company. On May 15, 2017 the Company completed the issuance of $2,194,443 7.5% Senior Secured Convertible Debentures (the "Debentures"), consisting of a principal amount of $1,755,554 and $438,889 of original issue discounts, and a maturity date of May 15, 2018. These Debentures were issued in exchange for 10% Convertible promissory notes with an aggregate prepayment amount of $1,755,554 that were maturing on various dates in May 2017 through October 2017. Of these Debentures $820,419 have a $0.12 conversion rate, $210,313 have a $0.13 conversion rate, and $1,163,711 have a $0.20 conversion rate. In conjunction with the transaction the Company issued 445,861 Series A Preferred as loan fees. On May 15, 2017 the Company issued Debentures in the aggregate principal amount of $1,179,581, with $235,916 in original issue discounts, in resulting in gross proceeds of $943,664.39 to the Company. Each of these Debentures have a conversion rate of $0.20. The Company issued 235,917 of Series A Preferred as loan fees on these Debentures. In connection with this financing the Company paid commissions of $75,493 to Chardan. In April and May, 2017, the Company issued 1,920,000 shares of common stock for 192,000 shares of Series A Preferred.

Basis of Presentation and Sig16

Basis of Presentation and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2017 and December 31, 2016, the balances reported for cash, prepaid expenses, accounts receivable, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis were calculated using the Black-Scholes pricing model and are as follows at March 31, 2017 and December 31, 2016: March 31, 2017 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 89,464 $ $ $ 89,464 Total Liabilities Measured at Fair Value $ 89,464 $ - $ - $ 89,464 December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 324,532 $ $ $ 324,532 Total Liabilities Measured at Fair Value $ 324,532 $ - $ - $ 324,532
Recent Accounting Pronouncements	Recent Accounting Pronouncements There are no recently issued accounting pronouncements that the Company believes are applicable or would have a material impact on the financial statements of the Company.

Basis of Presentation and Sig17

Basis of Presentation and Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2017
Basis Of Presentation And Significant Accounting Policies Tables
Schedule of Fair Value of Financial Instruments	The Company measures certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis were calculated using the Black-Scholes pricing model and are as follows at March 31, 2017 and December 31, 2016: March 31, 2017 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 89,464 $ $ $ 89,464 Total Liabilities Measured at Fair Value $ 89,464 $ - $ - $ 89,464 December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 324,532 $ $ $ 324,532 Total Liabilities Measured at Fair Value $ 324,532 $ - $ - $ 324,532

Fixed Assets (Tables)

Fixed Assets (Tables)	3 Months Ended
	Mar. 31, 2017
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	Fixed assets consist of the following at March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 Production equipment $ 15,182 $ 1,938,532 Office equipment 14,593 32,769 29,775 1,971,301 Less accumulated depreciation (29,042 ) (1,969,828 ) $ 733 $ 1,473

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following at March 31, 2017 and December 31, 2016: March 31, 2017 December 31, 2016 License Fee $ - $ 112,500 Less accumulated amortization - (112,500 ) Patents and intellectual property - - Intangible assets net of accumulated amortization $ - $ -

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Schedule of Related Party Transaction	Rental expense for the three months ended March 31, 2017 and 2016 consisted of the following and is recorded in general and administrative expense: Three months ended March 31, 2017 Three months ended March 31, 2016 Office and warehouse space $ - $ - Corporate office 4,500 4,500 Total Rental Expense $ 4,500 $ 4,500

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2017
Convertible Notes Payable Tables
Schedule of Convertible Notes Payable	As of March 31, 2017 and December 31, 2016 the Company had the following convertible notes outstanding: March 31, 2017 December 31, 2016 Principal (net) Accrued Interest Principal (net) Accrued Interest July and August 2012 $1,060,000 Notes convertible into common stock at $4.60 per share, 12% interest, due December 2013 and January 2014 $ 45,000 $ 25,161 $ 95,000 50,365 May through October 2015 $605,000 Notes convertible into preferred stock at $1 per share, 8-10% interest, due September 30, 2015 - 17,341 - 17,341 October through December 2015 $613,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016, net of debt discount of $0 and $560,913, respectively - 5,953 - 5,953 January through March 2016 $345,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016 - 696 - 696 November 2016 $979,162 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $156,788 and $540,720, respectively 822,374 36,547 438,442 12,397 January and March 2017 $335,838 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $142,918 and $0, respectively 192,920 4,090 - - Penalties on notes in default 10,910 - 11,066 - Total Convertible Notes Payable, Net $ 1,071,204 $ 89,788 $ 544,508 $ 86,752

Common Stock Options and Warr22

Common Stock Options and Warrants (Tables)	3 Months Ended
	Mar. 31, 2017
Equity [Abstract]
Schedule Summarizes Changes in Stock Option	The following schedule summarizes the changes in the Company’s stock options: Weighted Weighted Options Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 2,402,500 $ 0.50-15 4.05 years $ - $ 0.81 Options granted - $ - - $ - Options exercised - $ - - $ - Options expired - $ - - $ - Balance at March 31, 2017 2,402,500 $ 0.50-15 3.81 years $ - $ 0.81 Exercisable at March 31, 2017 2,016,733 $ 0.50-15 3.73 years $ - $ 0.86
Schedule Summarizes Changes in Stock Warrants	The following schedule summarizes the changes in the Company’s stock warrants: Weighted Weighted Warrants Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 3,579,505 $ 0.10-10 0.52 years $ 749 $ 4.45 Warrants granted - $ - - $ Warrants exercised - $ - - $ Warrants expired/cancelled (15,000 ) $ - - $ 2.07 Balance at March 31, 2017 3,564,505 $ 0.40-10 0.28 years $ - $ 4.46 Exercisable at March 31, 2017 3,564,505 $ 0.40-10 0.28 years $ - $ 4.46

Basis of Presentation and Sig23

Basis of Presentation and Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Derivative Liability	$ 89,464	$ 324,532
Total Liabilities Measured at Fair Value	89,464	324,532
Level 1 [Member]
Derivative Liability
Total Liabilities Measured at Fair Value
Level 2 [Member]
Derivative Liability
Total Liabilities Measured at Fair Value
Level 3 [Member]
Derivative Liability	89,464	324,532
Total Liabilities Measured at Fair Value	$ 89,464	$ 324,532

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Current operation activities	$ 1,500,000
Retire outstanding debt	1,500,000
Convertible promissory notes	45,000
Cash on hand	23,700	$ 27,889
Minimum [Member]
Capital	5,000,000
Maximum [Member]
Capital	$ 10,000,000

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 740	$ 738

Fixed Assets - Schedule of Fixe

Fixed Assets - Schedule of Fixed Assets (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Total Fixed assets	$ 29,775	$ 1,971,301
Less accumulated depreciation	(29,042)	(1,969,828)
Net Fixed assets	733	1,473
Production Equipment [Member]
Total Fixed assets	15,182	1,938,532
Office Equipment [Member]
Total Fixed assets	$ 14,593	$ 32,769

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Intangible Assets Details Narrative
Amortization expense of intangible assets

Intangible Assets - Schedule o

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
License Fee		$ 112,500
Less accumulated amortization		(112,500)
Patents and intellectual property
Intangible assets net of accumulated amortization

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Accrued interest payable	$ 89,788	$ 86,752
Related party promissory note	383,771	$ 332,195
Payment of rent	1,500
Director [Member]
Accrued interest payable	$ 51,576

Related Party Transaction - Sch

Related Party Transaction - Schedule of Related Party Transaction (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Related Party Transactions [Abstract]
Office and warehouse space
Corporate office	4,500	4,500
Total Rental Expense	$ 4,500	$ 4,500

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Proceeds from convertible note payable	$ 131,669	$ 641,760
Gain on settlement of debt	147,710
Amortization of debt	$ 462,928	$ 299,773
Number of shares issued	280,000
Series A Preferred Stock [Member]
Number of shares issued	9,182,100
Convertible Notes Payable [Member]
Proceeds from convertible note payable	$ 131,669
Advances from shareholders	137,000
Debt original issue discounts	67,169
Payment of convertible note payable	50,000
Gain on settlement of debt	5,831
Increase in debt discount	90,322
Amortization of debt	462,928
Convertible Notes Payable [Member] | Series A Preferred Stock [Member]
Increase in debt discount	$ 64,424
Number of shares issued	49,320

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Principal (net)	$ 1,071,204	$ 544,508
Accrued Interest	89,788	86,752
Penalties on notes past due principal (net)	10,910	11,066
Penalties on notes in default accrued interest
Convertible Notes Payable One [Member]
Principal (net)	45,000	95,000
Accrued Interest	25,161	50,365
Convertible Notes Payable Two [Member]
Principal (net)
Accrued Interest	17,341	17,341
Convertible Notes Payable Three [Member]
Principal (net)
Accrued Interest	5,953	5,953
Convertible Notes Payable Four [Member]
Principal (net)
Accrued Interest	696	696
Convertible Notes Payable Five [Member]
Principal (net)	822,374	438,442
Accrued Interest	36,547	12,397
Convertible Notes Payable Six [Member]
Principal (net)	192,920
Accrued Interest	$ 4,090

Convertible Notes Payable - S33

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) (Parenthetical) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Convertible Notes Payable One [Member]
Debt principal amount	$ 1,060,000
Debt conversion price per share	$ 4.60
Debt interest rate	12.00%
Debt maturity date description	December 2013 and January 2014
Convertible Notes Payable Two [Member]
Debt principal amount	$ 605,000
Debt conversion price per share	$ 1
Debt maturity date description	September 30, 2015
Convertible Notes Payable Two [Member] | Minimum [Member]
Debt interest rate	8.00%
Convertible Notes Payable Two [Member] | Maximum [Member]
Debt interest rate	10.00%
Convertible Notes Payable Three [Member]
Debt principal amount	$ 613,000
Debt conversion price per share	$ 1
Debt interest rate	8.00%
Debt maturity date description	June 30, 2016
Debt discount	$ 0	$ 560,913
Convertible Notes Payable Four [Member]
Debt principal amount	$ 345,000
Debt conversion price per share	$ 1
Debt interest rate	8.00%
Debt maturity date description	June 30, 2016
Convertible Notes Payable Five [Member]
Debt principal amount	$ 979,162
Debt conversion price per share
Debt interest rate	10.00%
Debt maturity date description	May 2,017
Debt discount	$ 156,788	540,720
Convertible Notes Payable Six [Member]
Debt principal amount	$ 335,838
Debt interest rate	10.00%
Debt maturity date description	May 2,017
Debt discount	$ 142,918	$ 0

Common Stock Options and Warr34

Common Stock Options and Warrants - Schedule Summarizes Changes in Stock Option (Details) - Stock Options	3 Months Ended
	Mar. 31, 2017USD ($)$ / sharesshares
Number Of Shares Options Outstanding Beginning Balance | shares	2,402,500
Number of Options Granted | shares
Number of Options Exercised | shares
Number of Options Expired | shares
Number Of Shares Options Outstanding Ending Balance | shares	2,402,500
Number Of Shares Options Exercisable Ending Balance | shares	2,016,733
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Expired
Weighted Average Remaining Contractual Life (in years) Outstanding, Beginning	4 years 18 days
Weighted Average Remaining Contractual Life (in years) Outstanding, Ending	3 years 9 months 22 days
Weighted Average Remaining Contractual Life (in years) Exercisable	3 years 8 months 23 days
Aggregate Intrinsic Value Outstanding | $
Aggregate Intrinsic Value Exercisable | $
Weighted Average Exercise Price Per Share Outstanding Beginning	$ 0.81
Weighted Average Exercise Price Per Share Options Granted
Weighted Average Exercise Price Per Share Options Exercised
Weighted Average Exercise Price Per Share Options Expired
Weighted Average Exercise Price Per Share Outstanding Ending	0.81
Weighted Average Exercise Price Per Share Exercisable	0.86
Minimum [Member]
Weighted Average Exercise Price Outstanding	0.50
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Outstanding	0.50
Exercise Price Per Share Exercisable	0.50
Maximum [Member]
Weighted Average Exercise Price Outstanding	15
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Outstanding	15
Exercise Price Per Share Exercisable	$ 15

Common Stock Options and Warr35

Common Stock Options and Warrants - Schedule Summarizes Changes in Stock Warrants (Details) - Warrants [Member]	3 Months Ended
	Mar. 31, 2017USD ($)$ / sharesshares
Number of Shares, Warrants Outstanding Beginning | shares	3,579,505
Number of Shares, Warrants Granted | shares
Number of Shares, Warrants Exercised | shares
Number of Shares, Warrants expired/cancelled | shares	(15,000)
Number of Shares, Warrants Outstanding Ending | shares	3,564,505
Number of Shares, Warrants Exercisable Ending | shares	3,564,505
Exercise Price Per Share Warrants Granted
Exercise Price Per Share Warrants Exercised
Exercise Price Per Share Warrants Expired/cancelled
Weighted Average Remaining Contractual Life (in years) Warrants Outstanding, Beginning	6 months 7 days
Weighted Average Remaining Contractual Life (in years) Warrants Outstanding Ending	3 months 11 days
Weighted Average Remaining Contractual Life (in years) Warrants Exercisable	3 months 11 days
Aggregate Intrinsic Value Outstanding | $	$ 749
Aggregate Intrinsic Value Outstanding | $
Aggregate Intrinsic Value Exercisable | $
Weighted Average Exercise Price Per Share Exercise Price Warrants Beginning	$ 4.45
Weighted Average Exercise Price Per Share Exercise Price Warrants Granted
Weighted Average Exercise Price Per Share Exercise Price Warrants Exercised
Weighted Average Exercise Price Per Share Exercise Price Warrants Expired/cancelled	2.07
Weighted Average Exercise Price Per Share Exercise Price Warrants Ending	4.46
Weighted Average Exercise Price Per Share Exercise Price Warrants Exercisable	4.46
Minimum [Member]
Weighted Average Exercise Price Outstanding	0.10
Weighted Average Exercise Price Outstanding	0.10
Exercise Price Per Share Exercisable	0.10
Maximum [Member]
Weighted Average Exercise Price Outstanding	10
Weighted Average Exercise Price Outstanding	10
Exercise Price Per Share Exercisable	$ 10

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative)	3 Months Ended
	Mar. 31, 2017USD ($)shares
Number of shares issued	280,000
Number of shares issued, value | $	$ 43,400
Series A Preferred Stock [Member]
Number of shares issued	9,182,100
Number of shares issued, value | $	$ 2,464,762
Common stock issued for debt conversions, shares	858,210
Settlement of Debt [Member]
Number of shares issued	762,000
Number of shares issued, value | $	$ 99,060
Accounts Payable [Member]
Number of shares issued	280,000
Number of shares issued, value | $	$ 43,400
Convertible Promissory Note [Member] | Series A Preferred Stock [Member]
Number of shares issued	49,320
Number of shares issued, value | $	$ 64,424

Supplemental Cash Flow Inform37

Supplemental Cash Flow Information (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Increase in convertible note payable	$ 5,675
Increase in related party debt	51,576
Decrease in accrued interest	57,251
Increase in derivative liabilities	90,322
Increased convertible notes payable and decreased loan from shareholder	$ 137,000
Number of preferred stock shares issued for loan fees on convertible promissory notes	49,320
Number of preferred stock issued for loan fees on convertible promissory notes	$ 64,424
Number of shares issued	280,000
Number of shares issued, value	$ 43,400
Gain on extinguishment of debt	96,600
Accrued interest	$ 91,151	$ 114,755
Series A Preferred Stock [Member]
Number of shares issued	9,182,100
Issued shares of common stock in exchange for preferred stock	858,210
Decrease in preferred stock	$ 2,464,762
Increase in common stock	9,182
Increase in additional paid in capital	2,455,580
Number of shares issued, value	$ 2,464,762
Common Stock [Member]
Number of shares issued	762,000
Number of shares issued, value	$ 99,060
Gain on extinguishment of debt	21,282
Reduction amount	50,000
Accrued interest	$ 27,778

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	May 31, 2017	May 15, 2017	Apr. 30, 2017	Mar. 31, 2017	Mar. 31, 2016
Number of shares issued				280,000
Proceeds from debt				$ 131,669	$ 641,760
Series A Preferred Stock [Member]
Number of shares issued				9,182,100
Common Stock [Member]
Number of shares issued				762,000
Subsequent Event [Member]
Debt principal amount			$ 43,750
Debt interest rate			10.00%
Debt maturity date			Oct. 13, 2017
Number of shares issued			825,000
Accounts payable			$ 86,767
Subsequent Event [Member] | Chardan Capital Markets [Member]
Commission paid	$ 75,493
Subsequent Event [Member] | 7.5% Senior Secured Convertible Debentures [Member]
Debt principal amount		$ 1,755,554
Debt interest rate		10.00%
Debt maturity date		May 15, 2018
Debt maturity date description		May 2017 through October 2017
Proceeds from debt		$ 2,194,443
Repayments of debt		1,755,554
Subsequent Event [Member] | 7.5% Senior Secured Convertible Debentures One [Member]
Debt principal amount		1,179,581
Debt discount		235,916
Proceeds from debt		$ 820,419
Debt instrument, conversion price rate		$ 0.12
Subsequent Event [Member] | 7.5% Senior Secured Convertible Debentures Two [Member]
Proceeds from debt		$ 210,313
Debt instrument, conversion price rate		$ 0.13
Subsequent Event [Member] | 7.5% Senior Secured Convertible Debentures Three [Member]
Proceeds from debt		$ 1,163,711
Debt instrument, conversion price rate		$ 0.20
Subsequent Event [Member] | Series A Preferred Stock [Member]
Number of shares issued	192,000	235,916	12,600
Debt discount		$ 1,179,581
Proceeds from debt		$ 943,664
Debt instrument, conversion price rate		$ 0.20
Subsequent Event [Member] | Series A Preferred Stock [Member] | 7.5% Senior Secured Convertible Debentures [Member]
Number of shares issued		445,861
Subsequent Event [Member] | Common Stock [Member]
Number of shares issued	1,920,000